ACB
Price
$5.33
Change
+$0.03 (+0.57%)
Updated
Aug 27 closing price
Capitalization
297.73M
70 days until earnings call
OGI
Price
$1.67
Change
+$0.02 (+1.21%)
Updated
Aug 27 closing price
Capitalization
223.36M
Interact to see
Advertisement

ACB vs OGI

Header iconACB vs OGI Comparison
Open Charts ACB vs OGIBanner chart's image
Aurora Cannabis
Price$5.33
Change+$0.03 (+0.57%)
Volume$1.24M
Capitalization297.73M
Organigram Global
Price$1.67
Change+$0.02 (+1.21%)
Volume$660.03K
Capitalization223.36M
ACB vs OGI Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. OGI commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a StrongBuy and OGI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (ACB: $5.33 vs. OGI: $1.67)
Brand notoriety: ACB: Notable vs. OGI: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACB: 83% vs. OGI: 85%
Market capitalization -- ACB: $297.73M vs. OGI: $223.36M
ACB [@Pharmaceuticals: Generic] is valued at $297.73M. OGI’s [@Pharmaceuticals: Generic] market capitalization is $223.36M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 1 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 1 green, 4 red.
According to our system of comparison, OGI is a better buy in the long-term than ACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while OGI’s TA Score has 7 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 5 bearish.
  • OGI’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, OGI is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а +12.92% price change this week, while OGI (@Pharmaceuticals: Generic) price change was +11.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.19%. For the same industry, the average monthly price growth was +10.32%, and the average quarterly price growth was +79.93%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.19% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($298M) has a higher market cap than OGI($223M). OGI has higher P/E ratio than ACB: OGI (192.90) vs ACB (19.44). ACB YTD gains are higher at: 25.412 vs. OGI (3.727). ACB has higher annual earnings (EBITDA): 26.6M vs. OGI (-959K). ACB has more cash in the bank: 140M vs. OGI (36.8M). OGI has less debt than ACB: OGI (9.15M) vs ACB (102M). ACB has higher revenues than OGI: ACB (358M) vs OGI (224M).
ACBOGIACB / OGI
Capitalization298M223M134%
EBITDA26.6M-959K-2,774%
Gain YTD25.4123.727682%
P/E Ratio19.44192.9010%
Revenue358M224M160%
Total Cash140M36.8M380%
Total Debt102M9.15M1,115%
FUNDAMENTALS RATINGS
ACB vs OGI: Fundamental Ratings
ACB
OGI
OUTLOOK RATING
1..100
2576
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9288
PRICE GROWTH RATING
1..100
5945
P/E GROWTH RATING
1..100
921
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (59) in the Pharmaceuticals Other industry is in the same range as OGI (88) in the null industry. This means that ACB’s stock grew similarly to OGI’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as OGI (100) in the null industry. This means that ACB’s stock grew similarly to OGI’s over the last 12 months.

OGI's SMR Rating (88) in the null industry is in the same range as ACB (92) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to ACB’s over the last 12 months.

OGI's Price Growth Rating (45) in the null industry is in the same range as ACB (59) in the Pharmaceuticals Other industry. This means that OGI’s stock grew similarly to ACB’s over the last 12 months.

OGI's P/E Growth Rating (1) in the null industry is significantly better than the same rating for ACB (92) in the Pharmaceuticals Other industry. This means that OGI’s stock grew significantly faster than ACB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBOGI
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCFNF0.04N/A
+2.91%
MCF ENERGY LTD
CMRB4.880.08
+1.67%
First Commerce Bancorp Inc.
ISMAY20.030.03
+0.12%
Indra Sistemas SA
AKEJF35.12N/A
N/A
Ariake Japan
RBSPF7.46-0.23
-2.99%
NatWest Group plc

OGI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGI has been closely correlated with SNDL. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if OGI jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGI
1D Price
Change %
OGI100%
+1.21%
SNDL - OGI
67%
Closely correlated
+2.43%
ACB - OGI
63%
Loosely correlated
+0.57%
CGC - OGI
62%
Loosely correlated
+2.72%
TLRY - OGI
61%
Loosely correlated
-5.52%
CRON - OGI
59%
Loosely correlated
+0.39%
More